Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Heavy metals in personal care products can cause serious health issues like cancer and hair loss.

Hair straightening can damage hair and pose health risks, including exposure to carcinogens and hair loss.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Coloring shampoos for gray hair may cause gene mutation, reproductive issues, and skin damage, needing stricter regulation and expert consultation.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Finasteride treats baldness but may cause lasting sexual side effects.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Ganoderma lucidum can cause severe skin reactions and hair loss.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Skin treatments can improve both skin health and emotional well-being, but they require careful management of patient expectations and potential addiction risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.